Exact Mass: 423.0655

Exact Mass Matches: 423.0655

Found 37 metabolites which its exact mass value is equals to given mass value 423.0655, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cephapirin

(6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(pyridin-4-ylsulfanyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C17H17N3O6S2 (423.0559)


Cephapirin is an injectable, first-generation cephalosporin antibiotic that has a wide spectrum of activity against gram-positive and gram-negative organisms. The bactericidal activity of cephapirin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cephapirin is more resistant to beta-lactamases than the penicillins, and therefore is effective against staphylococci, with the exception of methicillin-resistant staphylococci. Cephapirin is FDA approved for use in food-producing animals, especially dairy cattle. Cephapirin is used for the treatment of mastitis in cows. Production for use in humans has been discontinued in the United States. It is marketed under the trade name Cefadyl. Active against gram-positive and -negative bacteria (vet. use). FDA approved for use in food producing animals, especies dairy cattle. It is used for the treatment of mastitis in cows J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Gluconasturtiin

{[(e)-(3-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}propylidene)amino]oxy}sulphonic acid

C15H21NO9S2 (423.0658)


Isolated from Nasturtium officinale (water cress), Barbarea vulgaris (winter cress) and other crucifers. Gluconasturtiin is found in many foods, some of which are radish, broccoli, watercress, and brassicas. Gluconasturtiin is found in brassicas. Gluconasturtiin is isolated from Nasturtium officinale (water cress), Barbarea vulgaris (winter cress) and other crucifers. Acquisition and generation of the data is financially supported in part by CREST/JST.

   

Xanthommatin

Xanthommatin

C20H13N3O8 (423.0703)


An ommochrome that consists of a pyrido[3,2-a]phenoxazine ring system bearing hydroxy, carboxy, oxo and 3-amino-3-carboxypropanoyl substituents at positions 1, 3, 5 and 11 respectively. The parent of the class of xanthommatins.

   

Ethyl 3-cyano-6-methyl-2-({2-[(2-thienylcarbonyl)amino]phenyl}thio)isonicotinate

Ethyl 3-cyano-6-methyl-2-({2-[(2-thienylcarbonyl)amino]phenyl}thio)isonicotinate

C21H17N3O3S2 (423.0711)


   
   

Gluconasturtiin

1-S-[(1Z)-3-phenyl-N-(sulfooxy)propanimidoyl]-1-thio-beta-D-glucopyranose

C15H21NO9S2 (423.0658)


An aralkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 3-phenyl-N-(sulfooxy)propanimidoyl group at the anomeric sulfur.

   

Antibiotic PB 5266C

Antibiotic PB 5266C

C12H17N5O10S (423.0696)


   

Glucosinalbate

[(E)-[2-(4-hydroxyphenyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylethylidene]amino]methanesulfonic acid

C15H21NO9S2 (423.0658)


   

Cefadyl

3-[(acetyloxy)methyl]-8-oxo-7-[2-(pyridin-4-ylsulfanyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C17H17N3O6S2 (423.0559)


   

2-([4-(2-Chlorophenyl)-3-ethoxycarbonyl-6-hydroxymethyl-2-picolinyl]methoxyacetic acid

2-([4-(2-Chlorophenyl)-3-ethoxycarbonyl-6-hydroxymethyl-2-picolinyl]methoxyacetic acid

C19H18ClNO8 (423.0721)


   

2-(4-CARBOXYPHENOXY)-2-PIVALOYL-2,4-DICHLOROACETANILIDE

2-(4-CARBOXYPHENOXY)-2-PIVALOYL-2,4-DICHLOROACETANILIDE

C20H19Cl2NO5 (423.064)


   
   

Thiazolidine, 3-[(4-methyl-3,5-dinitrophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

Thiazolidine, 3-[(4-methyl-3,5-dinitrophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C17H17N3O6S2 (423.0559)


   

1-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-((2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY)PHENYL)UREA

1-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-((2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY)PHENYL)UREA

C19H13ClF3N3O3 (423.0597)


   

ethyl 5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxylate

ethyl 5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxylate

C19H13ClF3N3O3 (423.0597)


   

Cefuroxime Sodium EP Impurity G

Cefuroxime Sodium EP Impurity G

C17H17N3O8S (423.0736)


   

potassium 4-[4-[[4-(dimethylamino)phenyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate

potassium 4-[4-[[4-(dimethylamino)phenyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate

C19H18KN3O4S (423.0655)


   

SKF 83822 hydrobromide

SKF 83822 hydrobromide

C20H23BrClNO2 (423.0601)


   

(6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H15N4O8S- (423.0611)


   

[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-3-phenyl-N-sulfooxypropanimidothioate

[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-3-phenyl-N-sulfooxypropanimidothioate

C15H21NO9S2 (423.0658)


   

(11Z)-11-(3-azaniumyl-3-carboxylato-1-oxidopropylidene)-1,5-dioxo-4,12a-dihydropyrido[3,2-a]phenoxazine-3-carboxylate

(11Z)-11-(3-azaniumyl-3-carboxylato-1-oxidopropylidene)-1,5-dioxo-4,12a-dihydropyrido[3,2-a]phenoxazine-3-carboxylate

C20H13N3O8-2 (423.0703)


   

Diethyl 2-[[2-(2,4-dichlorophenoxy)anilino]methylidene]propanedioate

Diethyl 2-[[2-(2,4-dichlorophenoxy)anilino]methylidene]propanedioate

C20H19Cl2NO5 (423.064)


   

tetrakis(pyridine)silver(II)

tetrakis(pyridine)silver(II)

C20H20AgN4 (423.0739)


   

4-chloro-N-[[[oxo-(3,4,5-trimethoxyphenyl)methyl]hydrazo]-sulfanylidenemethyl]benzamide

4-chloro-N-[[[oxo-(3,4,5-trimethoxyphenyl)methyl]hydrazo]-sulfanylidenemethyl]benzamide

C18H18ClN3O5S (423.0656)


   

methyl 2-[(4-fluoro-2-nitrophenyl)carbamothioylamino]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate

methyl 2-[(4-fluoro-2-nitrophenyl)carbamothioylamino]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate

C18H18FN3O4S2 (423.0723)


   

N-{[5-(1,3-benzothiazol-2-ylsulfanyl)-2-furyl]methylene}-2-(2-methylphenoxy)acetohydrazide

N-{[5-(1,3-benzothiazol-2-ylsulfanyl)-2-furyl]methylene}-2-(2-methylphenoxy)acetohydrazide

C21H17N3O3S2 (423.0711)


   

2-chloro-N-(2-nitrophenyl)-5-(1-piperidinylsulfonyl)benzamide

2-chloro-N-(2-nitrophenyl)-5-(1-piperidinylsulfonyl)benzamide

C18H18ClN3O5S (423.0656)


   

N-[2-(2-chlorophenyl)-1,3-benzoxazol-5-yl]-2-(4-nitrophenoxy)acetamide

N-[2-(2-chlorophenyl)-1,3-benzoxazol-5-yl]-2-(4-nitrophenoxy)acetamide

C21H14ClN3O5 (423.0622)


   

Cephapirin

Cephapirin

C17H17N3O6S2 (423.0559)


A cephalosporin with acetoxymethyl and 2(pyridin-4-ylsulfanyl)acetamido substituents at positions 3 and 7, respectively, of the cephem skeleton. It is used (as its sodium salt) as an antibiotic, being effective against gram-negative and gram-positive organisms. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Phenethyl glucosinolate

Phenethyl glucosinolate

C15H21NO9S2 (423.0658)


   

PXL770

PXL770

C23H18ClNO3S (423.0696)


PXL770 is a direct AMP kinase activator. PXL770 can be used in the research of non-alcoholic fatty liver disease (NAFLD)[1].

   

(6r,7r)-3-[(acetyloxy)methyl]-7-{[1-hydroxy-2-(pyridin-4-ylsulfanyl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6r,7r)-3-[(acetyloxy)methyl]-7-{[1-hydroxy-2-(pyridin-4-ylsulfanyl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C17H17N3O6S2 (423.0559)


   

[(3-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

[(3-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

C15H21NO9S2 (423.0658)


   

6-[(3s)-3-amino-3-carboxypropanoyl]-4-hydroxy-12-oxo-10-oxa-1,5-diazatetraphene-2-carboxylic acid

6-[(3s)-3-amino-3-carboxypropanoyl]-4-hydroxy-12-oxo-10-oxa-1,5-diazatetraphene-2-carboxylic acid

C20H13N3O8 (423.0703)


   

[(e)-(3-phenyl-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

[(e)-(3-phenyl-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

C15H21NO9S2 (423.0658)


   

[(z)-(3-phenyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

[(z)-(3-phenyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

C15H21NO9S2 (423.0658)


   

[(z)-(3-phenyl-1-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

[(z)-(3-phenyl-1-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

C15H21NO9S2 (423.0658)